Investor Relations
Month Year
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
Month Year
Su | Mo | Tu | We | Th | Fr | Sa |
---|---|---|---|---|---|---|
-
Mar 20, 2020Company accelerates U.S. sales of COVID-19 test pursuant to new FDA policy
-
Feb 24, 2020Logix Smart™ COVID-19 Test now available for export from the United States as a CE-marked IVD
-
Feb 20, 2020Company’s new Logix Smart™ COVID-19 Test expected to be available with CE marking in February 2020
-
Feb 6, 2020Product launch and rapid development of the Logix Smart™ 2019-nCoV coronavirus test facilitated by Company’s proprietary technology platform
-
Feb 4, 2020Coronavirus assay will be addressed in webinar, as well as development of an innovative multiplex application of Company’s technology for mosquito populations
-
Jan 31, 2020Components of recently designed novel coronavirus assay have successfully passed initial verification
-
Jan 30, 2020Co-Diagnostics Inc CEO Interviewed on Fox Business with Maria Bartiromo as Coronavirus Concerns RiseInterviews on Fox Business and other programs discussed issues surrounding the novel strain of the coronavirus and the Company’s plan to provide a diagnostic solution
-
Jan 29, 2020
-
Jan 28, 2020Interview covered method of transmission, importance of accurate diagnostic tools, and the Company diagnostic announced last week
-
Jan 23, 2020Proprietary Company design process facilitates rapid response to health emergencies
-
Jan 14, 2020Co-Diagnostics’ CoPrimer platform, licensed by LGC, Biosearch, successfully used by Bayer to develop assays for multiplex PCR
-
Jan 2, 2020CoSara tests for tuberculosis, malaria, hepatitis B, hepatitis C, and human papillomavirus recently granted regulatory approval by CDSCO to formally launch at India Diagnostic Expo
-
Dec 10, 2019Vector Smart™ NAM-e multiplex PCR test to provide proactive defense against mosquito populations carrying the deadly eastern equine encephalitis virus
-
Dec 3, 2019CoSara Saragene™ tests for tuberculosis, malaria, hepatitis B, hepatitis C, and human papillomavirus now available for sale and distribution as in vitro diagnostics
-
Nov 13, 2019Revenue includes sales of infectious disease, mosquito abatement products and AgBio primer design services
-
Oct 29, 2019Company completes sale and installation to one of the largest private molecular diagnostics labs in Ghana
-
Oct 15, 2019Vector Smart™ products being presented at 6 vector control conferences in October to prepare for 2020 mosquito season
-
Oct 10, 2019Vector Smart™ ZDC multiplex PCR test to aid prevention of tropical disease proliferation in the US and abroad
-
Sep 19, 2019Company will host booth to introduce and promote mosquito abatement products to midwestern states in Tulsa, OK on Sept 19-20
-
Sep 4, 2019Expansion to include increased royalties and cover additional applications for Company’s technology platform
-
Aug 21, 2019Event to include demos and training for distributors and end-users of Company’s products
-
Aug 14, 2019Q2 revenue reflects increase over Q1, as US sales of mosquito abatement products and AgBio primer design services gain momentum